Trastuzumab, a monoclonal antibody used in the treatment of HER2-positive breast cancer, has significantly advanced cancer therapy by targeting the HER2 receptor, which is overexpressed in certain breast cancer cases. As the need for more affordable treatment options grows, trastuzumab biosimilars have emerged as a crucial solution, enhancing access to essential therapies while reducing overall...